PMC:7796052 / 15772-15988 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"400","span":{"begin":21,"end":31},"obj":"Gene"},{"id":"401","span":{"begin":183,"end":188},"obj":"Gene"},{"id":"405","span":{"begin":60,"end":70},"obj":"Chemical"}],"attributes":[{"id":"A400","pred":"tao:has_database_id","subj":"400","obj":"Gene:3827"},{"id":"A401","pred":"tao:has_database_id","subj":"401","obj":"Gene:2852"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The discovery of the bradykinin pharmacodynamics profile of raloxidene explains in part its observed vascular beneficial effects, although they could also be due to activation of the GPR30 receptor signaling pathway."}

{"project":"LitCovid-sentences","denotations":[{"id":"T110","span":{"begin":0,"end":216},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The discovery of the bradykinin pharmacodynamics profile of raloxidene explains in part its observed vascular beneficial effects, although they could also be due to activation of the GPR30 receptor signaling pathway."}